Clinical Trials Directory

Trials / Completed

CompletedNCT04765839

Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations

Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With Minority Populations

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
74 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years – 101 Years
Healthy volunteers
Accepted

Summary

A cluster randomized trial will be conducted prior to widespread vaccine availability to the general public. Community-informed COVID-19 vaccine messages will be disseminated to participants. At baseline, 2 weeks and 4 weeks, the study team will survey participants to assess knowledge and attitudes about COVID-19 vaccines, including intention to be vaccinated.

Detailed description

A cluster randomized trial with 80 participants from the social networks of 8 CLs will be conducted prior to widespread vaccine availability to the general public. Four CLs and social networks (cluster of 10 per network) will be randomly assigned to receive the intervention immediately or after a delay of 2 weeks. Intervention participants will be invited to a closed social media group on the platform of their choice. CLs, selected for trustworthiness within vulnerable populations, will disseminate community-informed COVID-19 vaccine messages to members of their social networks and engage in bidirectional communication with CEnR partners to refine messages. At baseline, 2 weeks and 4 weeks, participants will be surveyed to assess knowledge and attitudes about COVID-19 vaccines, including intention to be vaccinated.

Conditions

Interventions

TypeNameDescription
OTHEREducational, culturally appropriate COVID-19 messagesEducational, culturally appropriate COVID-19 messages will be developed and shared by RHCP.

Timeline

Start date
2021-02-12
Primary completion
2021-04-03
Completion
2021-04-03
First posted
2021-02-23
Last updated
2021-07-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04765839. Inclusion in this directory is not an endorsement.